SVASINOVAC BIOTECH LTDvs its industry peers
A metric-by-metric comparison of SINOVAC BIOTECH LTD against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SVAThis | — | — | — | — | 6.8%#2 | -589.1%#6 | -127.0%#3 | -4.5%#2 | -11.0%#2 | 3#2 | — | — |
| SMMT | $12.8B#4 | — | 20.2x#3 | — | — | -387.8%#5 | — | -171.4%#4 | — | — | -8.6%#3 | — |
| SMNR | — | — | — | — | — | -3320.4%#7 | — | — | — | — | — | — |
| SMNRW | — | — | — | — | — | -3320.4%#7 | — | — | — | — | — | — |
| SNY | $57.7B#1 | — | — | — | — | — | — | — | — | — | -3.6%#2 | — |
| SPRC | $192479#6 | — | — | 0.1x#1 | -54.6%#5 | -22.7%#2 | -560.2%#4 | — | — | — | -98.2%#4 | — |
| SXTC | $3M#5 | — | 0.1x#1 | 2.8x#2 | -34.6%#4 | -87.8%#3 | -625.9%#5 | -20.9%#3 | -281.4%#3 | — | -100.0%#5 | — |
| TAK | $32.7B#3 | — | — | — | — | — | — | — | — | — | 54.7%#1 | — |
| TEVA | $48.8B#2 | 97.3x#1 | 6.1x#2 | 2.8x#3 | 4.3%#3 | 186.0%#1 | 12.5%#1 | 17.7%#1 | 5.9%#1 | 7#1 | — | — |
| TLPPF | — | — | — | — | 55.6%#1 | -121.2%#4 | 3.7%#2 | — | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice